ZA978086B - New pyranoside derivatives. - Google Patents

New pyranoside derivatives.

Info

Publication number
ZA978086B
ZA978086B ZA9708086A ZA978086A ZA978086B ZA 978086 B ZA978086 B ZA 978086B ZA 9708086 A ZA9708086 A ZA 9708086A ZA 978086 A ZA978086 A ZA 978086A ZA 978086 B ZA978086 B ZA 978086B
Authority
ZA
South Africa
Prior art keywords
new
pyranoside
derivatives
pyranoside derivatives
new pyranoside
Prior art date
Application number
ZA9708086A
Other languages
English (en)
Inventor
Ralf Anderskewitz
Kurt Schromm
Ernst-Otto Renth
Franz Birke
Hans Michael Jennewein
Christopher John Montagu Meade
Andreas Ding
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of ZA978086B publication Critical patent/ZA978086B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA9708086A 1996-09-12 1997-09-09 New pyranoside derivatives. ZA978086B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19637123A DE19637123A1 (de) 1996-09-12 1996-09-12 Neue Pyranosidderivate

Publications (1)

Publication Number Publication Date
ZA978086B true ZA978086B (en) 1998-03-12

Family

ID=7805404

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9708086A ZA978086B (en) 1996-09-12 1997-09-09 New pyranoside derivatives.

Country Status (16)

Country Link
EP (1) EP0931087B1 (fr)
JP (1) JP4215278B2 (fr)
AR (1) AR009769A1 (fr)
AT (1) ATE215551T1 (fr)
AU (1) AU4622597A (fr)
CA (1) CA2263846C (fr)
DE (2) DE19637123A1 (fr)
DK (1) DK0931087T3 (fr)
ES (1) ES2174297T3 (fr)
HR (1) HRP970487A2 (fr)
ID (1) ID18262A (fr)
PE (1) PE107398A1 (fr)
PT (1) PT931087E (fr)
WO (1) WO1998011119A1 (fr)
YU (1) YU37597A (fr)
ZA (1) ZA978086B (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL141654A0 (en) * 1998-09-04 2002-03-10 Byk Gulden Lomberg Chem Fab Pyranose derivatives and pharmaceutical compositions containing the same
DE10052658A1 (de) * 2000-10-24 2002-05-02 Boehringer Ingelheim Pharma Neue Pyranosidderivate
US6528491B2 (en) 2000-10-24 2003-03-04 Boehringer Ingelheim Pharma Kg Pyranoside derivatives
JP2004523512A (ja) * 2001-01-16 2004-08-05 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト ムチン遺伝子の増大された発現により生じる疾患の治療及び／又は予防のためのｌｔｂ４アンタゴニストの使用
RU2004102399A (ru) * 2001-07-14 2005-05-27 Берингер Ингельхайм Фарма Гмбх Ко.Кг (De) Лекарственная композиция, содержащая ltb4-антагонист
EP3383388B1 (fr) 2015-11-30 2021-04-14 Merck Sharp & Dohme Corp. Utilisation d'arylacylsulfonamides en tant qu'antagonistes de blt1
WO2017095724A1 (fr) 2015-11-30 2017-06-08 Merck Sharp & Dohme Corp. Sulfonamides d'aryle utilisés en tant qu'antagonistes de blt1
EP3383869B1 (fr) 2015-11-30 2023-06-28 Merck Sharp & Dohme LLC Sulfonamides d'aryle utilisés en tant qu'antagonistes de blt1
WO2017095723A1 (fr) 2015-11-30 2017-06-08 Merck Sharp & Dohme Corp. Utilisation d'arylacylsulfonamides en tant qu'antagonistes de blt1
US20200199168A1 (en) * 2017-05-12 2020-06-25 Riken Class a gpcr-binding compound modifier

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246965A (en) * 1991-06-11 1993-09-21 Ciba-Geigy Arylethers, their manufacture and methods of treatment
ES2165122T3 (es) * 1992-02-05 2002-03-01 Boehringer Ingelheim Pharma Nuevos derivados de amidina, su preparacion y utilizacion como medicamentos con efecto antagonista de ltb4.
DE19546452A1 (de) * 1995-12-13 1997-06-19 Boehringer Ingelheim Kg Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
CA2263846A1 (fr) 1998-03-19
DE59706897D1 (de) 2002-05-08
DK0931087T3 (da) 2002-07-01
PE107398A1 (es) 1999-02-03
AR009769A1 (es) 2000-05-03
EP0931087A1 (fr) 1999-07-28
YU37597A (en) 1999-11-22
ES2174297T3 (es) 2002-11-01
ATE215551T1 (de) 2002-04-15
HRP970487A2 (en) 1998-08-31
PT931087E (pt) 2002-09-30
CA2263846C (fr) 2006-11-14
JP4215278B2 (ja) 2009-01-28
AU4622597A (en) 1998-04-02
EP0931087B1 (fr) 2002-04-03
JP2001500146A (ja) 2001-01-09
DE19637123A1 (de) 1998-03-19
WO1998011119A1 (fr) 1998-03-19
ID18262A (id) 1998-03-19

Similar Documents

Publication Publication Date Title
ZA97521B (en) 19-Nor-pregnene derivatives.
ZA961444B (en) Pyrazolylbenzoyl derivatives.
HRP970454B1 (en) Substituted 6,5-hetero-bicyclic derivatives
ZA977652B (en) Substituted 6,6-hetero-bicyclic derivatives
ZA9710429B (en) Broad-spectrumδ-endotoxins.
ZA99254B (en) Benzosulfone derivatives.
ZA961449B (en) Isoxazolylbenzoyl derivatives.
HK1018457A1 (en) Alkylaminobenzothiazole and-benzoxazole derivatives.
IL126624A0 (en) 3-descladinose-2, 3-anhydroerythromycin derivatives
ZA969973B (en) 2-thioxo-imidazolidin-4-one derivatives.
ZA991550B (en) Cyclohexanediole derivatives.
ZA974953B (en) Substituted pyrazolylpyrazole derivatives.
ZA967741B (en) Diarylalkenylamine derivatives.
ZA978086B (en) New pyranoside derivatives.
ZA979725B (en) Benzoaxozole derivative.
ZA982436B (en) Thiazolimine derivatives.
ZA962821B (en) 4-indolylpiperazinyl derivatives.
ZA967357B (en) Pyrazol-4-ylbenzoyl derivatives.
ZA983902B (en) Erythromycin derivatives.
ZA974052B (en) New benzothiazolinones.
CY2322B1 (en) Benzoaeguequinoline derivatives.
ZA971167B (en) Heterocyclyl-ergoline derivatives.
ZA988206B (en) Piperidinylmethyloxazolidinone derivative.
ZA971466B (en) Endothelin-receptor-antagonists.
ZA972302B (en) 1,25-Dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives.